Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 7—July 2024
Dispatch

Relapsed Mpox Keratitis, St. Louis, Missouri, USA

Cinthia Pi, Osasu Adah, Preetam A. Cholli, Roosecelis Martines, Getahun Abate, Lori Hainaut, Erich Seipel, T. Scott Isbell, Roddy Frankel, and Nongnooch PoowanawittayakomComments to Author 
Author affiliations: St. Louis University, St. Louis, Missouri, USA (C. Pi, O. Adah, G. Abate, L. Hainaut, E. Seipel, T.S. Isbell, R. Frankel, N. Poowanawittayakom); CDC, Atlanta, Georgia, USA (P.A. Cholli, R. Martines)

Main Article

Figure 1

Physical and ophthalmologic examination results over time of a 46-year-old patient in St. Louis, Missouri, USA, after receiving mpox and HIV diagnoses. The exam remained unchanged after day 44 despite treatment. IV, intravenous.

Figure 1. Physical and ophthalmologic examination results over time of a 46-year-old patient in St. Louis, Missouri, USA, after receiving mpox and HIV diagnoses. The exam remained unchanged after day 44 despite treatment. IV, intravenous.

Main Article

Page created: May 24, 2024
Page updated: June 22, 2024
Page reviewed: June 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external